Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Elfabrio Now Approved for Adults with Fabry Disease
    https://pixabay.com/en/youth-active-jump-happy-sunrise-570881/

    Elfabrio Now Approved for Adults with Fabry Disease

    On May 10, 2023, reports EMPR, the U.S. FDA approved Elfabrio (pegunigalsidase alfa-iwxj) for adults who are living with Fabry disease. Developed by Protalix Biotherapeutics in conjunction with Chiesi Global…

    Continue Reading Elfabrio Now Approved for Adults with Fabry Disease
    Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia
    https://pixabay.com/en/american-football-football-sports-1666276/

    Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia

    In 2014, head coach Jimbo Fisher led the Florida State Seminoles to win the BCS National Championship Game. He’s now head coach of the Texas A&M Aggies, recently deemed by…

    Continue Reading Aggies’ Head Coach Jimbo Fisher Says Gene Therapy Could Cure Son’s Fanconi Anemia
    Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer
    mohamed_hassan / Pixabay

    Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer

      On May 18, 2023, Market Watch reported that rucosopasem manganese received Orphan Drug designation. Developed by clinical stage biopharmaceutical company Galera Therapeutics (“Galera”), rucosopasem manganese is largely being developed…

    Continue Reading Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer
    Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?
    source: pixabay.com

    Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?

    In 2014, the National Heart, Lung, and Blood Institute released updated clinical guidelines in reference to the care of children with sickle cell anemia. The updated guidelines recommended the use…

    Continue Reading Hydroxyurea is Recommended for Children with Sickle Cell Anemia. So Why Does It Remain Underused?
    OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies
    source: pixabay.com

    OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies

      ABCA4-associated retinopathies are a group of conditions that cause progressive macular degeneration and vision loss due to ABCA4 mutations. Stargardt disease, cone-rod dystrophy type 3 (CORD3), and retinitis pigmentosa 19…

    Continue Reading OCU410ST Granted Orphan Drug Designation for ABCA4-Associated Retinopathies
    Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress
    source: shutterstock.com

    Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: From the 1960s to Now: How Two Hemophilia Advocates Have Seen Treatment and Research Progress
    Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing
    source: shutterstock.com

    Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: How Derrick’s Colorectal Cancer Journey Led Him to Advocate for Increased Biomarker Testing